Vir Biotechnology (VIR) Interest & Investment Income (2018 - 2026)

Vir Biotechnology has reported Interest & Investment Income for 9 years, with the latest figure at $7.2 million in Q1 2026.

• Quarterly Interest & Investment Income fell 41.5% year-over-year to $7.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $35.1 million (down 44.06% YoY) and the FY2025 annual result came in at $40.2 million, down 43.97% from the prior year.
• Interest & Investment Income declined to $7.2 million in Q1 2026 per VIR's latest filing, from $7.8 million in the prior quarter.
• Over five years, Interest & Investment Income peaked at $23.0 million in Q2 2023 and troughed at $388000.0 in Q1 2022.
• A 5-year average of $13.8 million and a median of $14.2 million in 2024 frame the typical range for Interest & Investment Income.
• The sharpest annual moves came in 2022 and 2025: Interest & Investment Income jumped 84736.36% in 2022, then slumped 46.58% in 2025.
• Over 5 years, Interest & Investment Income stood at $16.2 million in 2022, then rose by 28.22% to $20.7 million in 2023, then slumped by 31.75% to $14.2 million in 2024, then sank by 44.87% to $7.8 million in 2025, then declined by 7.86% to $7.2 million in 2026.
• According to Business Quant data, Interest & Investment Income over the past three periods registered $7.2 million, $7.8 million, and $9.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.